Annual D&A
$473.67M$8.96M-1.86%
Summary
- Current Value
- As of today, GRFS annual D&A is $473.67M, down -1.86% on
- Historical Performance
- GRFS annual D&A is up +11.39% over the past 3 years, and up +39.92% over the past 5 years
- All-Time High Comparison
- GRFS annual D&A is currently -1.86% below its historical high of $482.63M set on
- 3-Year Low Comparison
- GRFS annual D&A is +10.50% above its 3-year low of $428.65M reached on an earlier date
- Sector Comparison
- GRFS annual D&A is higher than 94.92% of companies in Healthcare sector
Depreciation & Amortization Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual D&A | $473.67M | -1.9% | +11.4% | +39.9% | +761.3% | |
| Quarterly D&A | $124.53M | +5.6% | – | +32.4% | – | |
| TTM D&A | $484.22M | +3.4% | – | +36.5% | – | |
| Price | $9.49 | +24.9% | +6.4% | -51.6% | – | |
| Annual SG&A | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | |
| Annual Total Expenses | $7.63B | +7.8% | +36.1% | +52.4% | +617.3% | |
| Annual Operating Expenses | $1.63B | -7.1% | +9.6% | +31.1% | +556.7% | |
| Annual Revenue | $7.80B | +9.5% | +33.8% | +36.7% | +514.4% |
Depreciation & Amortization Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $482.63M | -1.9% | |
| 5Y | $482.63M | -1.9% | |
| All | $482.63M | -1.9% |
Depreciation & Amortization Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $428.65M | N/A | +10.5% |
| 5Y | $366.54M | N/A | +29.2% |
| All | $16.47M | +2775.2% |
Depreciation & Amortization History
FAQ
What is the current annual D&A of GRFS?
As of today, GRFS annual D&A is $473.67M
What is 1-year change in GRFS annual D&A?
GRFS annual D&A is down -1.86% year-over-year
What is 3-year change in GRFS annual D&A?
GRFS annual D&A is up +11.39% over the past 3 years
How far is GRFS annual D&A from its all-time high?
GRFS annual D&A is currently -1.86% below its historical high of $482.63M set on December 31, 2023
How does GRFS annual D&A rank versus sector peers?
GRFS annual D&A is higher than 94.92% of companies in Healthcare sector
When is GRFS next annual earnings release?
The next annual earnings release for GRFS is on
Quarterly D&A
$124.53M$4.19M+3.48%
Summary
- Current Value
- As of today, GRFS quarterly D&A is $124.53M, up +3.48% on
- Historical Performance
- GRFS quarterly D&A is up +5.57% year-over-year, with unknown 3-year change
- All-Time High Comparison
- GRFS quarterly D&A is currently at its all-time high
- 3-Year Low Comparison
- GRFS quarterly D&A is +10.08% above its 3-year low of $113.13M reached on
- Sector Comparison
- GRFS quarterly D&A is higher than 94.84% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly D&A | $124.53M | +3.5% | +5.6% | – | +32.4% | |
| Annual D&A | $473.67M | – | -1.9% | +11.4% | +39.9% | |
| TTM D&A | $484.22M | +1.4% | +3.4% | – | +36.5% | |
| Price | $9.49 | 0.0% | +24.9% | +6.4% | -51.6% | |
| Quarterly SG&A | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | |
| Quarterly Total Expenses | $2.03B | +0.9% | +6.2% | +21.9% | +60.0% | |
| Quarterly Operating Expenses | $446.40M | +7.7% | -0.2% | +4.1% | +22.7% | |
| Quarterly Revenue | $2.18B | +1.6% | +10.7% | +31.7% | +37.8% |
Quarterly D&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $124.53M | at high | |
| 3Y | $124.53M | at high | |
| 5Y | $124.53M | at high | |
| All | $124.53M | at high |
Quarterly D&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $117.61M | +5.9% | |
| 3Y | $113.13M | +10.1% | |
| 5Y | $98.21M | N/A | +26.8% |
| All | $17.02M | +631.8% |
Quarterly D&A History
| Month | Value | Change |
|---|---|---|
| $124.53M | +3.5% | |
| $120.34M | +2.3% | |
| $117.61M | -3.4% | |
| $121.73M | +3.2% | |
| $117.96M | -3.7% |
| Month | Value | Change |
|---|---|---|
| $122.46M | +6.6% | |
| $114.90M | +1.6% | |
| $113.13M | -4.6% | |
| $118.56M | - |
FAQ
What is the current quarterly D&A of GRFS?
As of today, GRFS quarterly D&A is $124.53M
What is GRFS quarterly D&A most recent change?
GRFS quarterly D&A was up +3.48% on September 1, 2025
What is 1-year change in GRFS quarterly D&A?
GRFS quarterly D&A is up +5.57% year-over-year
How far is GRFS quarterly D&A from its all-time high?
GRFS quarterly D&A is currently at its all-time high
How does GRFS quarterly D&A rank versus sector peers?
GRFS quarterly D&A is higher than 94.84% of companies in Healthcare sector
When is GRFS next earnings release?
The next earnings release for GRFS is on
TTM D&A
$484.22M$6.57M+1.37%
Summary
- Current Value
- As of today, GRFS TTM D&A is $484.22M, up +1.37% on
- Historical Performance
- GRFS TTM D&A is up +3.36% year-over-year, with unknown 3-year change
- All-Time High Comparison
- GRFS TTM D&A is currently at its all-time high
- 3-Year Low Comparison
- GRFS TTM D&A is +308.43% above its 3-year low of $118.56M reached on
- Sector Comparison
- GRFS TTM D&A is higher than 94.75% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM D&A | $484.22M | +1.4% | +3.4% | – | +36.5% | |
| Annual D&A | $473.67M | – | -1.9% | +11.4% | +39.9% | |
| Quarterly D&A | $124.53M | +3.5% | +5.6% | – | +32.4% | |
| Price | $9.49 | 0.0% | +24.9% | +6.4% | -51.6% | |
| TTM SG&A | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | |
| TTM Revenue | $8.31B | +2.6% | +9.4% | +159.9% | +37.7% |
TTM D&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $484.22M | at high | |
| 3Y | $484.22M | at high | |
| 5Y | $484.22M | at high | |
| All | $484.22M | at high |
TTM D&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $477.06M | N/A | +1.5% |
| 3Y | $118.56M | +308.4% | |
| 5Y | $118.56M | +308.4% | |
| All | $17.02M | +2745.4% |
TTM D&A History
| Month | Value | Change |
|---|---|---|
| $484.22M | +1.4% | |
| $477.65M | -0.4% | |
| $479.77M | +0.6% | |
| $477.06M | +1.8% | |
| $468.45M | -0.1% |
| Month | Value | Change |
|---|---|---|
| $469.05M | +35.3% | |
| $346.58M | +49.6% | |
| $231.68M | +95.4% | |
| $118.56M | - |
FAQ
What is the current TTM D&A of GRFS?
As of today, GRFS TTM D&A is $484.22M
What is GRFS TTM D&A most recent change?
GRFS TTM D&A was up +1.37% on September 1, 2025
What is 1-year change in GRFS TTM D&A?
GRFS TTM D&A is up +3.36% year-over-year
How far is GRFS TTM D&A from its all-time high?
GRFS TTM D&A is currently at its all-time high
How does GRFS TTM D&A rank versus sector peers?
GRFS TTM D&A is higher than 94.75% of companies in Healthcare sector
When is GRFS next earnings release?
The next earnings release for GRFS is on
Data Sources & References
- GRFS Official Website www.grifols.com
- GRFS Profile on Yahoo Finance finance.yahoo.com/quote/GRFS
- GRFS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/grfs